Literature DB >> 26963489

Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.

Lindsey M Weiner1, Scott K Fridkin, Zuleika Aponte-Torres, Lacey Avery, Nicole Coffin, Margaret A Dudeck, Jonathan R Edwards, John A Jernigan, Rebecca Konnor, Minn M Soe, Kelly Peterson, L Clifford McDonald.   

Abstract

BACKGROUND: Health care-associated antibiotic-resistant (AR) infections increase patient morbidity and mortality and might be impossible to successfully treat with any antibiotic. CDC assessed health care-associated infections (HAI), including Clostridium difficile infections (CDI), and the role of six AR bacteria of highest concern nationwide in several types of health care facilities.
METHODS: During 2014, approximately 4,000 short-term acute care hospitals, 501 long-term acute care hospitals, and 1,135 inpatient rehabilitation facilities in all 50 states reported data on specific infections to the National Healthcare Safety Network. National standardized infection ratios and their percentage reduction from a baseline year for each HAI type, by facility type, were calculated. The proportions of AR pathogens and HAIs caused by any of six resistant bacteria highlighted by CDC in 2013 as urgent or serious threats were determined.
RESULTS: In 2014, the reductions in incidence in short-term acute care hospitals and long-term acute care hospitals were 50% and 9%, respectively, for central line-associated bloodstream infection; 0% (short-term acute care hospitals), 11% (long-term acute care hospitals), and 14% (inpatient rehabilitation facilities) for catheter-associated urinary tract infection; 17% (short-term acute care hospitals) for surgical site infection, and 8% (short-term acute care hospitals) for CDI. Combining HAIs other than CDI across all settings, 47.9% of Staphylococcus aureus isolates were methicillin resistant, 29.5% of enterococci were vancomycin-resistant, 17.8% of Enterobacteriaceae were extended-spectrum beta-lactamase phenotype, 3.6% of Enterobacteriaceae were carbapenem resistant, 15.9% of Pseudomonas aeruginosa isolates were multidrug resistant, and 52.6% of Acinetobacter species were multidrug resistant. The likelihood of HAIs caused by any of the six resistant bacteria ranged from 12% in inpatient rehabilitation facilities to 29% in long-term acute care hospitals.
CONCLUSIONS: Although there has been considerable progress in preventing some HAIs, many remaining infections could be prevented with implementation of existing recommended practices. Depending upon the setting, more than one in four of HAIs excluding CDI are caused by AR bacteria. IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: Physicians, nurses, and health care leaders need to consistently and comprehensively follow all recommendations to prevent catheter- and procedure-related infections and reduce the impact of AR bacteria through antimicrobial stewardship and measures to prevent spread.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26963489     DOI: 10.15585/mmwr.mm6509e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  21 in total

1.  Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015-2017.

Authors:  Lindsey M Weiner-Lastinger; Sheila Abner; Jonathan R Edwards; Alexander J Kallen; Maria Karlsson; Shelley S Magill; Daniel Pollock; Isaac See; Minn M Soe; Maroya S Walters; Margaret A Dudeck
Journal:  Infect Control Hosp Epidemiol       Date:  2019-11-26       Impact factor: 3.254

2.  Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.

Authors:  Wan-Jou Shen; Aditi Deshpande; Kirk E Hevener; Bradley T Endres; Kevin W Garey; Kelli L Palmer; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2020-04-01       Impact factor: 5.790

Review 3.  Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship.

Authors:  Philippe Morency-Potvin; David N Schwartz; Robert A Weinstein
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

4.  Long-term efficacy of comprehensive multidisciplinary antibiotic stewardship programs centered on weekly prospective audit and feedback.

Authors:  Takeshi Kimura; Atsushi Uda; Tomoyuki Sakaue; Kazuhiko Yamashita; Tatsuya Nishioka; Sho Nishimura; Kei Ebisawa; Manabu Nagata; Goh Ohji; Tatsuya Nakamura; Chihiro Koike; Mari Kusuki; Takeshi Ioroi; Akira Mukai; Yasuhisa Abe; Hiroyuki Yoshida; Midori Hirai; Soichi Arakawa; Ikuko Yano; Kentaro Iwata; Issei Tokimatsu
Journal:  Infection       Date:  2017-11-13       Impact factor: 3.553

5.  Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins.

Authors:  Atsushi Uda; Takeshi Kimura; Sho Nishimura; Kei Ebisawa; Goh Ohji; Mari Kusuki; Mariko Yahata; Rie Izuta; Tomoyuki Sakaue; Tatsuya Nakamura; Chihiro Koike; Issei Tokimatsu; Ikuko Yano; Kentaro Iwata; Takayuki Miyara
Journal:  Infection       Date:  2019-10-11       Impact factor: 3.553

6.  Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.

Authors:  Pratik Bhagunde; Francheska Colon-Gonzalez; Yang Liu; Jin Wu; Shiyao Sherrie Xu; Graigory Garrett; Patricia Jumes; Kenneth Lasseter; Thomas Marbury; Matthew L Rizk; Mallika Lala; Elizabeth G Rhee; Joan R Butterton; Keith Boundy
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

7.  Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints.

Authors:  April M Bobenchik; Eszter Deak; Janet A Hindler; Carmen L Charlton; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2016-11-23       Impact factor: 5.948

8.  Visualizing Infection Surveillance Data for Policymaking Using Open Source Dashboarding.

Authors:  Monika Maya Wahi; Natasha Dukach
Journal:  Appl Clin Inform       Date:  2019-07-24       Impact factor: 2.342

9.  Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.

Authors:  Lindsey M Weiner; Amy K Webb; Brandi Limbago; Margaret A Dudeck; Jean Patel; Alexander J Kallen; Jonathan R Edwards; Dawn M Sievert
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

Review 10.  Economic Evaluation of Quality Improvement Interventions for Bloodstream Infections Related to Central Catheters: A Systematic Review.

Authors:  Teryl K Nuckols; Emmett Keeler; Sally C Morton; Laura Anderson; Brian Doyle; Marika Booth; Roberta Shanman; Jonathan Grein; Paul Shekelle
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.